• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

MannKind Corp

NASDAQ:MNKD

$1.71 $0.01 (0.59%)

REAL-TIME: Last trade at

2 Promising Medical Companies Near Their Lows

Shorter Timeframe, More Risky

Why Mannkind Has Long-Term Value

Wall Street's Buy List

MannKind Narrows Loss - Analyst Blog

Best of the Blogs, Biotech: Will New HIV Prevention Pill Create More Dangerous Strains?

MannKind Teams Up with Tolero - Analyst Blog

MannKind Rents Out a Drug Program

This Just In: More Upgrades and Downgrades

Charting a Course to Profit

Still Neutral on MannKind - Analyst Blog

1 Thing to Know Before Betting on the Next Blockbuster Drug

MannKind Narrows Loss - Analyst Blog

Down 35%, Mannkind No Bargain

Tomorrow's Monster Stock

This Just In: Upgrades and Downgrades

5 of Last Week's Biggest Losers

Why Did My Stock Just Die?

The Week's Biggest Stock Laggards

MannKind Treads the Neutral Path - Analyst Blog

The Worst Health Care Stocks of 2011

Here's What Some Big-Time Quants Are Buying

MannKind in Neutral Lane - Analyst Blog

7 Black Friday Biotech Bargains

The Highest-Rated Biopharma Stocks

January Effect Boosting Stock Prices: Here Are the Possible Winners

These 2 Biotechs Got Crushed

Biotech Blunder Turned 20% Overnight Gain

5 Superball Stocks

Against the Herd: If Everyone Else is Selling Stocks, Should You?

Against the Herd: If Everyone Else Is Selling Stocks, Should You?

This Just In: Upgrades and Downgrades

A Drug Market That's 366 Million Strong

Investors Guide to the New PDUFA

3 Stocks Stopping the Presses

Investing 101: Short-Squeeze Ideas With Insider Buying

Investing 101: Short Squeeze Ideas with Insider Buying

MannKind Rises on Bond Offering

Dendreon's Provenge Greediness Leaves Stock Messy, Shareholders Unhappy

Investing 101: Stocks Under $5 With Insider Buying

See More Articles...